Hopes, Predictions and Realities: Is Biomedical Research Delivering On Its Promises?

October 22, 2007

Dr. Nurse, 2001 Nobel Prize winner in Medicine, will appear at Sixth & I for a critical examination of the latest breakthroughs in the biological sciences and their potential to transform medical treatment. Dr. Nurse spent over three decades as a research scientist in the United Kingdom, where he was born. His research led to the identification of cyclin-dependent kinase (CDK) as the key regulator molecule controlling the process by which cells make copies of themselves. This is important for understanding growth, development and cancer. His most recent post was as head of the world's largest volunteer-supported cancer research organization, Cancer Research UK.

Laura Landro, editor and award winning writer for The Wall Street Journal will interview Dr. Nurse about biomedical research in general, cancer research in particular, and his passionate commitment to promoting fruitful dialogue between scientists and society.

In 1991, Laura Landro was diagnosed with a form of blood cancer called chronic myelogenous leukemia. Over the course of the months and years that followed, she used her training as a reporter to obtain critical information about the disease affecting her, improving her ability to interact with her doctors and eventually emerging as a survivor. Laura won the National Print Journalism Award from the Leukemia Society of America for her WSJ article, "A Survivor's Tale," and is the author of Survivor: Taking Control of Your Fight Against Cancer; she remains an outspoken advocate of patient empowerment through education.
-end-
Sixth & I Historic Synagogue is a magnificent newly restored historic synagogue that is now a cutting-edge cultural center. Sixth & I is a non-denominational, non-membership, non-traditional synagogue in the heart of downtown Washington. We are committed to providing world-class programming and a variety of exceptional services to its target audience of young and unaffiliated Jews, particularly in the 20-35 age groups, as well as to the general community at large.

Rockefeller University

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.